New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Elevai Labs, Inc. Common Stock
ELAB
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

5M

Biotechnology

0.09USD
Shape-0.00Ā ( -3.80%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-62%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

98%

Quote Panel

Shape
Updated October 12, 2024
1W -10.85 % 1M -73.23 % 3M -81.38 % 1Y -97.24 %

Key Metrics

Shape
  • Market Cap

    4.63M


  • Shares Outstanding

    49.38M


  • Share in Float

    37.40M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.0937


  • Average Volume

    14.31M


  • Beta

    0


  • Range

    0.078-4.244


  • Industry

    Biotechnology


  • Website


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.87x

P/S Ratio

0.65x

P/B Ratio

0.1

Debt/Equity

-192.1%

Net Margin

$-0.4

EPS

How ELAB compares to sector?

P/E Ratio

Relative Strength

Shape

ELAB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

N/A

NA
vsĀ NA

Q4.23

arrow
arrow

N/A

-0.08
vsĀ NA

Q1.24

arrow
arrow

N/A

-0.08
vsĀ NA

Q2.24

arrow
arrow

N/A

-0.08
vsĀ NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

+28%

554.7KĀ  vsĀ 432.1K

Q4.23

arrow
arrow

+403%

698.6KĀ  vsĀ 138.9K

Q1.24

arrow
arrow

+330%

614.6KĀ  vsĀ 142.8K

Q2.24

arrow
arrow

+91%

605.5KĀ  vsĀ 316.5K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-58%

-0.58
vsĀ -0.44

Q1.23

arrow
arrow

NA

NA
vsĀ -0.58

Q2.23

arrow
arrow

-1902%

-19.02
vsĀ NA

Q3.23

arrow
arrow

+478%

4.78
vsĀ -19.02

Q4.23

arrow
arrow

-30%

-0.30
vsĀ 4.78

Q1.24

arrow
arrow

-56%

-0.56
vsĀ -0.30

Q2.24

arrow
arrow

-54%

-0.54
vsĀ -0.56

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News